ArticleUnited European gastroenterology journal2018

Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial.

Axel Dignass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.